ACETYLCYSTEINE INJECTION SOLUTION
Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
Tabia za bidhaa
(SPC)
01-02-2023
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
ACETYLCYSTEINE
Inapatikana kutoka:
EUGIA PHARMA INC.
ATC kanuni:
R05CB01
INN (Jina la Kimataifa):
ACETYLCYSTEINE
Kipimo:
200MG
Dawa fomu:
SOLUTION
Tungo:
ACETYLCYSTEINE 200MG
Njia ya uendeshaji:
INTRAVENOUS
Vitengo katika mfuko:
100
Dawa ya aina:
Ethical
Bidhaa muhtasari:
Active ingredient group (AIG) number: 0100024001; AHFS:
Idhini hali ya:
APPROVED
Idhini ya tarehe:
2023-02-03
Tabia za bidhaa
Page 1 of 18
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
ACETYLCYSTEINE INJECTION
200 mg / mL
Sterile Solution for Injection
House Standard
Antidote for Acetaminophen Poisoning
Eugia Pharma Inc.
3700 Steeles Avenue West, Suite # 402
Woodbridge, Ontario
L4L 8K8, Canada
Submission Control No.: 270744
Date
of
Preparation:
FEB 1, 2023
Page 2 of 18
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.....................................................................
3
SUMMARY PRODUCT INFORMATION
.............................................................................
3
INDICATIONS AND CLINICAL USE
...................................................................................
3
CONTRAINDICATIONS
.....................................................................................................
3
WARNINGS AND PRECAUTIONS
.....................................................................................
3
ADVERSE REACTIONS
....................................................................................................
5
DRUG INTERACTIONS
.....................................................................................................
5
DOSAGE AND ADMINISTRATION
....................................................................................
5
OVERDOSAGE
................................................................................................................
10
ACTION AND CLINICAL PHARMACOLOGY
................................................................... 10
STORAGE AND
STABILITY.............................................................................................
11
SPECIAL HANDLING INSTRUCTIONS
...........................................................................
11
DOSAGE FORMS, COMPOSITION AND PACKAGING
................................................... 11
PART II: SCIENTIFIC INFORMATION
..........................................................................................
12
PHARMACEUTICAL INFORMATION
.....................................
Soma hati kamili
